Abstract
Immunoglobulin rearrangement from variable heavy chain (VH) to diversity (D)–joining heavy chain (JH), which occurs exclusively in B lineage cells, is impaired in mice deficient for the B lineage–specific transcription factor Pax5. Conversely, ectopic Pax5 expression in thymocytes promotes the rearrangement of DH-proximal VH7183 genes. In exploring the mechanism for Pax5 regulation of VH-to-DJH recombination, we have identified multiple Pax5 binding sites in the coding regions of human and mouse VH gene segments. Pax5 bound to those sites in vitro and occupied VH genes in early human and mouse B lineage cells. Moreover, Pax5 interacted with the recombination-activating gene 1 (RAG1)–RAG2 complex to enhance RAG-mediated VH recombination signal sequence cleavage and recombination of a VH gene substrate. These findings indicate a direct activating function for Pax5 in RAG-mediated immunoglobulin VH-to-DJH recombination.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Tonegawa, S. Somatic generation of antibody diversity. Nature 302, 575–581 (1983).
Rajewsky, K. Clonal selection and learning in the antibody system. Nature 381, 751–758 (1996).
Bassing, C.H., Swat, W. & Alt, F.W. The mechanism and regulation of chromosomal V(D)J recombination. Cell 109, S45–S55 (2002).
Schatz, D.G., Oettinger, M.A. & Baltimore, D. The V(D)J recombination activating gene, RAG-1. Cell 59, 1035–1048 (1989).
Oettinger, M.A., Schatz, D.G., Gorka, C. & Baltimore, D. RAG-1 and RAG-2, adjacent genes that synergistically activate V(D)J recombination. Science 248, 1517–1523 (1990).
Lewis, S.M. The mechanism of V(D)J joining: lessons from molecular, immunological, and comparative analyses. Adv. Immunol. 56, 27–150 (1994).
Gellert, M. V(D)J recombination: RAG proteins, repair factors, and regulation. Annu. Rev. Biochem. 71, 101–132 (2002).
Igarashi, H., Gregory, S.C., Yokota, T., Sakaguchi, N. & Kincade, P.W. Transcription from the RAG1 locus marks the earliest lymphocyte progenitors in bone marrow. Immunity 17, 117–130 (2002).
Turka, L.A. et al. Thymocyte expression of RAG-1 and RAG-2: termination by T cell receptor cross-linking. Science 253, 778–781 (1991).
Grawunder, U. et al. Down-regulation of RAG1 and RAG2 gene expression in preB cells after functional immunoglobulin heavy chain rearrangement. Immunity 3, 601–608 (1995).
Sleckman, B.P., Gorman, J.R. & Alt, F.W. Accessibility control of antigen-receptor variable-region gene assembly: role of cis-acting elements. Annu. Rev. Immunol. 14, 459–481 (1996).
Yancopoulos, G.D. & Alt, F.W. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell 40, 271–281 (1985).
Blackwell, T.K. et al. Recombination between immunoglobulin variable region gene segments is enhanced by transcription. Nature 324, 585–589 (1986).
Schlissel, M.S. & Baltimore, D. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline κ gene transcription. Cell 58, 1001–1007 1989.
Stanhope-Baker, P., Hudson, K.M., Shaffer, A.L., Constantinescu, A. & Schlissel, M.S. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell 85, 887–897 (1996).
Roth, D.B. & Roth, S.Y. Unequal access: regulating V(D)J recombination through chromatin remodeling. Cell 103, 699–702 (2000).
Kwon, J., Imbalzano, A.N., Matthews, A. & Oettinger, M.A. Accessibility of nucleosomal DNA to V(D)J cleavage is modulated by RSS positioning and HMG1. Mol. Cell 2, 829–839 (1998).
Golding, A., Chandler, S., Ballestar, E., Wolffe, A.P. & Schlissel, M.S. Nucleosome structure completely inhibits in vitro cleavage by the V(D)J recombinase. EMBO J. 18, 3712–3723 (1999).
Kwon, J., Morshead, K.B., Guyon, J.R., Kingston, R.E. & Oettinger, M.A. Histone acetylation and hSWI/SNF remodeling act in concert to stimulate V(D)J cleavage of nucleosomal DNA. Mol. Cell 6, 1037–1048 (2000).
McMurry, M.T. & Krangel, M.S. A role for histone acetylation in the developmental regulation of V(D)J recombination. Science 287, 495–498 (2000).
Burrows, P., LeJeune, M. & Kearney, J.F. Evidence that murine pre-B cells synthesise μ heavy chains but no light chains. Nature 280, 838–840 (1979).
Kurosawa, Y. et al. Identification of D segments of immunoglobulin heavy-chain genes and their rearrangement in T lymphocytes. Nature 290, 565–570 (1981).
Lassoued, K. et al. Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell 73, 73–86 (1993).
Karasuyama, H. et al. The expression of Vpre-B/λ5 surrogate light chain in early bone marrow precursor B cells of normal and B cell-deficient mutant mice. Cell 77, 133–143 (1994).
Schebesta, M., Heavey, B. & Busslinger, M. Transcriptional control of B-cell development. Curr. Opin. Immunol. 14, 216–223 (2002).
Bain, G. et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell 79, 885–892 (1994).
Zhuang, Y., Soriano, P. & Weintraub, H. The helix-loop-helix gene E2A is required for B cell formation. Cell 79, 875–884 (1994).
Lin, H. & Grosschedl, R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature 376, 263–267 (1995).
Romanow, W.J. et al. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell 5, 343–353 (2000).
Ghosh, J.K., Romanow, W.J. & Murre, C. Induction of a diverse T cell receptor gamma/delta repertoire by the helix-loop-helix proteins E2A and HEB in nonlymphoid cells. J. Exp. Med. 193, 769–776 (2001).
Goebel, P. et al. Localized gene-specific induction of accessibility to V(D)J recombination induced by E2A and early B cell factor in nonlymphoid cells. J. Exp. Med. 194, 645–656 (2001).
Czerny, T., Schaffner, G. & Busslinger, M. DNA sequence recognition by Pax proteins: bipartite structure of the paired domain and its binding site. Genes Dev. 7, 2048–2061 (1993).
Czerny, T. & Busslinger, M. DNA-binding and transactivation properties of Pax-6: three amino acids in the paired domain are responsible for the different sequence recognition of Pax-6 and BSAP (Pax-5). Mol. Cell. Biol. 15, 2858–2871 (1995).
Urbanek, P., Wang, Z.Q., Fetka, I., Wagner, E.F. & Busslinger, M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79, 901–912 (1994).
Hesslein, D.G. et al. Pax5 is required for recombination of transcribed, acetylated, 5′ IgH V gene segments. Genes Dev. 17, 37–42 (2003).
Roldan, E. et al. Locus 'decontraction' and centromeric recruitment contribute to allelic exclusion of the immunoglobulin heavy-chain gene. Nat. Immunol. 6, 31–41 (2005).
Fuxa, M. et al. Pax5 induces V-to-DJ rearrangements and locus contraction of the immunoglobulin heavy-chain gene. Genes Dev. 18, 411–422 (2004).
Hsu, L.Y., Liang, H.E., Johnson, K., Kang, C. & Schlissel, M.S. Pax5 activates immunoglobulin heavy chain V to DJ rearrangement in transgenic thymocytes. J. Exp. Med. 199, 825–830 (2004).
Sayegh, C., Jhunjhunwala, S., Riblet, R. & Murre, C. Visualization of looping involving the immunoglobulin heavy-chain locus in developing B cells. Genes Dev. 19, 322–327 (2005).
Wang, Y.H. et al. V(D)J recombinatorial repertoire diversification during intraclonal pro-B to B-cell differentiation. Blood 101, 1030–1037 (2003).
Zhang, Z. et al. Contribution of VH gene replacement to the primary B cell repertoire. Immunity 19, 21–31 (2003).
Kitamura, D., Roes, J., Kuhn, R. & Rajewsky, K.A. B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 350, 423–426 (1991).
Hiom, K. & Gellert, M. Assembly of a 12/23 paired signal complex: a critical control point in V(D)J recombination. Mol. Cell 1, 1011–1019 (1998).
Love, V.A., Lugo, G., Merz, D. & Feeney, A.J. Individual VH promoters vary in strength, but the frequency of rearrangement of those VH genes does not correlate with promoter strength nor enhancer-independence. Mol. Immunol. 37, 29–39 (2000).
Fitzsimmons, D. et al. Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter. Genes Dev. 10, 2198–2211 (1996).
Garvie, C.W., Hagman, J. & Wolberger, C. Structural studies of Ets-1/Pax5 complex formation on DNA. Mol. Cell 8, 1267–1276 (2001).
Eberhard, D., Jimenez, G., Heavey, B. & Busslinger, M. Transcriptional repression by Pax5 (BSAP) through interaction with corepressors of the Groucho family. EMBO J. 19, 2292–2303 (2000).
Eberhard, D. & Busslinger, M. The partial homeodomain of the transcription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and TATA-binding proteins. Cancer Res. 59, 1716s–1724s (1999).
Emelyanov, A.V., Kovac, C.R., Sepulveda, M.A. & Birshtein, B.K. The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J. Biol. Chem. 277, 11156–11164 (2002).
Maier, H. et al. Requirements for selective recruitment of Ets proteins and activation of mb-1/Ig-α gene transcription by Pax-5 (BSAP). Nucleic Acids Res. 31, 5483–5489 (2003).
Lieber, M.R., Hesse, J.E., Mizuuchi, K. & Gellert, M. Lymphoid V(D)J recombination: nucleotide insertion at signal joints as well as coding joints. Proc. Natl. Acad. Sci. USA 85, 8588–8592 (1988).
Acknowledgements
We thank M. Busslinger (Research Institute of Molecular Pathology, Vienna, Austria) for the Pax5 expression vectors and discussions; D. Roth (Baylor College of Medicine, Houston, Texas), M. Gellert (National Institutes of Health, Bethesda, Maryland) and D. Schatz (Yale University, New Haven, Connecticut) for the pEBG-RAG1, pEBG-RAG2, pJH289 and pJH290 vectors, protocols for RAG protein purification and in vitro cleavage assays, and discussions; S. Desiderio (Johns Hopkins University, Baltimore, Maryland) for antibodies to RAG1 and RAG2, pCDNA1-RAG1 and pCDNA1-RAG2 expression vectors, and suggestions; Y. Kubagawa for DNA sequencing; and members of the laboratories of M.D.C., Z.Z., A.J.F. and J.H. for discussions. Supported by the National Institutes of Health (AI39816 and AI48098; AI56322, AI54661 and CA107478 to J.H.; and AI52313 to the laboratory of A.J.F.), the National Institutes of Health–National Institute of Arthritis, Musculoskeletal and Skin Diseases (K01 AR048592 to Z.Z.) and the Howard Hughes Medical Institute (M.D.C.).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Fig. 1
Sequence alignment of candidate Pax5 binding sites from the VH genes with the consensus Pax5 binding sites. (PDF 16 kb)
Supplementary Fig. 2
Pax5 association with the VH1-8-Pax5 binding sites. (PDF 114 kb)
Supplementary Fig. 3
Pax5 association with the individual mouse VH gene Pax5 binding sites. (PDF 338 kb)
Supplementary Fig. 4
Interaction of Pax5 with the RAG1/RAG2 complex. (PDF 103 kb)
Supplementary Fig. 5
Effects of Pax5 on RAG-mediated cleavage and recombination. (PDF 46 kb)
Supplementary Fig. 6
Effects of Gal4-Pax5-ΔB on RAG-mediated recombination of pJH298-G4RSS constructs. (PDF 36 kb)
Supplementary Table 1
Identification of potential Pax5 binding sites within human VH1 family of VH genes. (PDF 40 kb)
Supplementary Table 2
Identification of potential Pax5 binding sites within human VH3 family of VH genes. (PDF 48 kb)
Supplementary Table 3
Identification of potential Pax5 binding sites within human VH4 family of VH genes. (PDF 38 kb)
Supplementary Table 4
Identification of potential Pax5 binding sites within mouse VHJ558 family of VH genes. (PDF 119 kb)
Supplementary Table 5
Identification of potential Pax5 binding sites within mouse VH7183 family of VH genes. (PDF 62 kb)
Supplementary Table 6
Identification of potential Pax5 binding sites within mouse VHS107 family of VH genes. (PDF 40 kb)
Supplementary Table 7
Summary of potential Pax5 binding sites within human and mouse VH genes. (PDF 35 kb)
Supplementary Table 8
Sequence analysis of V(D)J joint obtained from 293T cells expressing RAG1, RAG2, E47, and Pax5. (PDF 43 kb)
Supplementary Table 9
List of oligonucleotide sequences. (PDF 78 kb)
Rights and permissions
About this article
Cite this article
Zhang, Z., Espinoza, C., Yu, Z. et al. Transcription factor Pax5 (BSAP) transactivates the RAG-mediated VH-to-DJH rearrangement of immunoglobulin genes. Nat Immunol 7, 616–624 (2006). https://doi.org/10.1038/ni1339
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ni1339
This article is cited by
-
Epstein-Barr virus-negative diffuse large B cell lymphoma with aberrant expression of CD3 and other T cell-associated antigens: report of three cases with a review of the literature
Annals of Hematology (2016)
-
YY1 controls Igκ repertoire and B-cell development, and localizes with condensin on the Igκ locus
The EMBO Journal (2013)
-
Determinants of public T cell responses
Cell Research (2012)
-
Recombination centres and the orchestration of V(D)J recombination
Nature Reviews Immunology (2011)